Last reviewed · How we verify

NCT06879314

Development in Children Diagnosed With Congenital Muscular Torticollis

Completed Last updated 25 June 2025
What this trial tests

trial in Torticollis Congenital in 40 participants. Completed in 30 April 2025.

Timeline
13 March 2025
Primary endpoint
30 April 2025
30 April 2025

Quick facts

Lead sponsorGazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date13 March 2025
Primary completion30 April 2025
Estimated completion30 April 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Gazi University

Who can join

Adults 1 Month to 12 Months, any sex, with Torticollis Congenital or Motor Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It has been thought that head position may affect the shoulder, rib cage and abdominal muscles, which may have a negative effect on posture control and movement development, sensory-motor coordination and cause retardation in gross motor function. For these reasons, children with congenital muscular torticollis should be evaluated comprehensively in the early period. This study, which was planned to evaluate the motor development and sensory processing of children with torticollis, was designed according to the lack of literature.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Motor development and sensory processing skills in infants with congenital muscular torticollis: a cross-sectional study.
    Zorlular R, Burak SE, Beyoglu R, Elbasan B. · · 2025 · PMID 40986093 · DOI 10.1007/s00431-025-06457-2

Verify or expand the search:

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06879314.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing